Dana-Farber Cancer Institute /ID# 1140-0349

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Chronic Graft Versus Host Disease

Studies at this site

• Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD) — Completed